Reducing the Global Burden of Depression

Authors

  • Prabjyot Kaur Chahil Student, University of Ottawa, Canada

DOI:

https://doi.org/10.18192/riss-ijhs.v4i1.1221

Keywords:

Depression treatment, antidepressants, cognitive behavioral therapy, counseling, depression prevention

Abstract

Depression is expected to be one of the leading causes of morbidity by 2020. Nonetheless, the current methods of treatment for depression may not be effective in reducing the global burden of this disease. Currently, pharmacotherapy represents the first line treatment for depressive disorders; however, many adverse effects of anti-depressants are often overlooked and their interference with body chemistry may not be ideal for long-term treatment.

In order to reduce the burden of disease of depression, methods of treatment such as counseling and therapy should be considered as alternatives to pharmacotherapy. Most importantly, these treatments reduce the occurrence of depression relapse, making them more effective in the long-term. In addition to alternative methods of treatment, depression prevention strategies should be prioritized. Not only is depression prevention the best solution therapeutically, but it is also the most cost-effective in reducing global morbidity. In order to implement these strategies, however, more evidence-based research on the prevention of depressive disorders is required.

References

Andrews, P. W., Thomson, J. A., Jr., Amstadter, A., & Neale, M. C. (2012). Primum non nocere: An evolutionary analysis of whether antidepressants do more harm than good. Frontiers in Psychology, 3, 117. doi: 10.3389/fpsyg.2012.00117

Chilvers, C., Dewey, M., Fielding, K., Gretton, V., Miller, P., Palmer, B., … & Harrison, G. (2001). Antidepressant drugs and generic counselling for treatment of major depression in primary care: Randomised trial with patient preference arms. British Medical Journal, 322(7289), 772-776. doi: 10.1136/bmj.322.7289.772

Cuijpers, P., Beekman, A. T., & Reynolds, C. F., III. (2012). Preventing depression: A global priority. Journal of the American Medical Association, 307(10), 1033-1034. doi: 10.1001/jama.2012.271

DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008). Cognitive therapy vs. medications for depression: Treatment outcomes and neural mechanisms. Nature Reviews Neuroscience., 9(10), 788-796. doi: 10.1038/nrn2345

Khawam, E. A., Laurencic, G., & Malone, D. A., Jr. (2006). Side effects of antidepressants: An overview. Cleveland Clinic Journal of Medicine, 73(4), 351-353, 356-361.

Mayo Clinic. (2014). Depression (major depressive disorder). Retrieved May 9, 2014, from http://www.mayoclinic.org/diseasesconditions/depression/basics/prevention/con-20032977

Padala, P. R., Padala, K. P., Monga, V., Ramirez, D. A., & Sullivan, D. H. (2012). Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Annals of Pharmacotherapy, 46(3), e8. doi: 10.1345/aph.1Q656

Reddy, M. (2010). Depression: The disorder and the burden. Indian Journal of Psychological Medicine, 32(1), 1-2. doi: 10.4103/0253-7176.70510

Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358(3), 252-260. doi: 10.1056/NEJMsa065779

Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007). Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive behavioral therapy's effects. Journal of Consulting and Clinical Psychology, 75(3), 475-488.

World Health Organization. (2014). Metrics: Disability adjusted life year (DALY). Retrieved from http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/

Downloads

Published

2014-08-17

Issue

Section

Articles